| Catherine Kin Ho, DO | |
|
1855 E Southern Ave, Tempe, AZ 85282-5894 | |
| (480) 829-6100 | |
| (480) 446-7602 |
| Full Name | Catherine Kin Ho |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1855 E Southern Ave, Tempe, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881841963 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 006189 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Catherine Kin Ho, DO 1855 E Southern Ave Ste 215, Tempe, AZ 85282-5894 Ph: (480) 712-6000 | Catherine Kin Ho, DO 1855 E Southern Ave, Tempe, AZ 85282-5894 Ph: (480) 829-6100 |
News Archive
Insmed Incorporated, a biopharmaceutical company, today announced that it has begun screening patients for its U.S. phase 2 clinical trial, Treatment with ARIKACE to Realize Greater Efficacy Trial (TARGET-NTM), of ARIKACE (liposomal amikacin for inhalation) in patients with non-tuberculous mycobacterial (NTM) lung disease.
An interesting study led by scientists in the U.S. has recently revealed that the microbial community in the gut is directly affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and that virus-mediated gut microbiome dysbiosis may cause severe secondary infections in coronavirus disease 2019 (COVID-19) patients. The study is currently available on the bioRxiv* preprint server.
VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on December 29, 2009, it received a written notice from the listing qualifications staff of the NASDAQ Stock Market ("NASDAQ") informing the Company that trading of the Company's common stock would be suspended prior to the open of business on January 4, 2010 and that NASDAQ would initiate procedures to delist the Company's common stock.
Researchers at the Clemson University International Center for Automotive Research (CU-ICAR) and the psychology department have partnered with Perceptual Testing Inc. of San Diego to study the relationship between visual function, muscular coordination and driving.
BSD Medical Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a 510(k) clearance to market its MicroThermX Microwave Ablation System (MTX-180) for ablation of soft tissue. Clearance from the FDA of BSD's 510(k) Premarket Notification submission authorizes the commercial sale of the MTX-180 in the United States. The MTX-180 was designed to provide a higher power, optimized system targeted to the growing therapeutic interventional and surgical oncology market.
› Verified 9 days ago
Dr. Dilip K Bobra, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2055 East Southern Avenue, Suite A, Tempe, AZ 85282 Phone: 480-610-6602 | |
Jeffrey M Braxton, M.D., F.A.C.S. Surgery Medicare: Accepting Medicare Assignments Practice Location: 6301 S Mcclintock Dr Ste 115, Tempe, AZ 85283 Phone: 480-775-8460 Fax: 480-775-8464 | |
Alan Lee Ansel, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2034 E Southern, 4, Tempe, AZ 85282 Phone: 602-252-2133 Fax: 602-258-0123 | |
Dr. Thomas Buddensick, M.D. Surgery Medicare: May Accept Medicare Assignments Practice Location: 1855 E Southern Ave, Tempe, AZ 85282 Phone: 480-712-6000 | |
Clayton C.k. Knight, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 S Rural Rd Ste 207, Tempe, AZ 85288 Phone: 520-428-5644 | |
Joshua Hamilton, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1920 E Baseline Rd, Tempe, AZ 85283 Phone: 800-233-3264 | |
Dr. Alan I Josephson, Surgery Medicare: Medicare Enrolled Practice Location: 1804 W Elliot Rd, Tempe, AZ 85284 Phone: 480-456-0444 Fax: 480-456-0449 |